A carregar...
Ticagrelor Associated Heart Block: The Need for Close and Continued Monitoring
Ticagrelor is an antiplatelet agent prescribed to prevent the development of adverse cardiac events after acute coronary syndrome (ACS). According to the PLATO trial, ticagrelor is associated with ventricular pauses in the first week of treatment; however, these episodes were felt to be asymptomatic...
Na minha lista:
| Publicado no: | Case Rep Cardiol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi Publishing Corporation
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5299195/ https://ncbi.nlm.nih.gov/pubmed/28246559 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/5074891 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|